[HTML][HTML] Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery

AC Spyropoulos, A Al‐Badri, MW Sherwood… - Journal of Thrombosis …, 2016 - Elsevier
The periprocedural management of patients receiving chronic therapy with oral
anticoagulants (OACs), including vitamin K antagonists (VKAs) such as warfarin and direct …

CIRSE standards of practice on peri-operative anticoagulation management during interventional radiology procedures

M Hadi, C Walker, M Desborough, A Basile… - Cardiovascular and …, 2021 - Springer
CIRSE Standards of Practice on Peri-operative Anticoagulation Management During
Interventional Radiology Procedures | CardioVascular and Interventional Radiology Skip to …

[HTML][HTML] 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

CE Chiang, K Okumura, S Zhang, TF Chao, CW Siu… - Journal of arrhythmia, 2017 - Elsevier
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …

Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study

C Mauprivez, RH Khonsari, O Razouk, P Goudot… - Oral Surgery, Oral …, 2016 - Elsevier
Objective The main goal of this study was to compare the incidence of postoperative
bleeding events after dental extractions between patients treated with direct oral …

[HTML][HTML] Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter …

S Testa, C Legnani, A Tripodi, O Paoletti… - Journal of Thrombosis …, 2016 - Elsevier
Essentials• Prothrombin and partial thromboplastin time (PT/PTT) measure direct oral
anticoagulants (DOACs).• PT, PTT and specific tests for DOACs were performed on patients …

Bleeding related to dental treatment in patients taking novel oral anticoagulants (NOACs): A retrospective study

EJ Kwak, S Nam, K Park, S Kim, J Huh… - Clinical oral investigations, 2019 - Springer
Objective Several novel oral anticoagulants (NOACs) are currently prescribed for patients
suffering from atrial fibrillation, pulmonary thromboembolism, and venous thrombosis …

Italian intersociety consensus on DOAC use in internal medicine

D Prisco, W Ageno, C Becattini, A D'Angelo… - Internal and emergency …, 2017 - Springer
The direct oral anticoagulants (DOACs) are drugs used in clinical practice since 2009 for the
prevention of stroke or systemic embolism in non-valvular atrial fibrillation, and for the …

The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures

A Tripodi, F Marongiu, M Moia, G Palareti… - Internal and Emergency …, 2018 - Springer
Direct oral anticoagulants (DOAC) possess high bioavailability, and their anticoagulant
effect is more predictable than that of vitamin K antagonists, hence they do not require …

Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence

M Bo, E Grisoglio, E Brunetti, Y Falcone… - European Journal of …, 2017 - Elsevier
Atrial fibrillation is more frequent in older patients, who have a higher risk of cardioembolic
stroke and thromboembolism. Oral anticoagulant therapy is the standard of treatment for …

Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy

AD Oprea, CJ Noto, TM Halaszynski - Journal of Clinical Anesthesia, 2016 - Elsevier
As a result of the aging US population and the subsequent increase in the prevalence of
coronary disease and atrial fibrillation, therapeutic use of anticoagulants has increased …